Carboxylesterase inhibitors from clinically available medicines and their impact on drug metabolism

YQ Song, Q Jin, DD Wang, J Hou, LW Zou… - Chemico-Biological …, 2021 - Elsevier
Mammalian carboxylesterases (CES), the key members of the serine hydrolase superfamily,
hydrolyze a wide range of endogenous substances and xenobiotics bearing ester or amide …

[HTML][HTML] Human carboxylesterases: a comprehensive review

D Wang, L Zou, Q Jin, J Hou, G Ge, L Yang - Acta Pharmaceutica Sinica B, 2018 - Elsevier
Mammalian carboxylesterases (CEs) are key enzymes from the serine hydrolase
superfamily. In the human body, two predominant carboxylesterases (CES1 and CES2) …

Potential pharmacokinetic herb-drug interactions: have we overlooked the importance of human carboxylesterases 1 and 2?

J Xu, JC Qiu, X Ji, HL Guo, X Wang… - Current Drug …, 2019 - ingentaconnect.com
Background: Herbal products have grown steadily across the globe and have increasingly
been incorporated into western medicine for healthcare aims, thereby causing potential …

Recent progress in the discovery of natural inhibitors against human carboxylesterases

DD Wang, LW Zou, Q Jin, J Hou, GB Ge, L Yang - Fitoterapia, 2017 - Elsevier
Mammalian carboxylesterases (CEs) are important serine hydrolases catalyzing the
hydrolysis of ester-or amide-containing compounds into the corresponding alcohols and …

Regulations of xenobiotics and endobiotics on carboxylesterases: a comprehensive review

Y Xu, C Zhang, W He, D Liu - European journal of drug metabolism and …, 2016 - Springer
Carboxylesterases (CESs) play major roles in catalyzing the hydrolysis of a wide range of
ester-and amide-containing compounds. CESs dominate both the biotransformation of …

Natural products as modulators of CES1 activity

Y Qian, JS Markowitz - Drug Metabolism and Disposition, 2020 - ASPET
Carboxylesterase (CES) 1 is the predominant esterase expressed in the human liver and is
capable of catalyzing the hydrolysis of a wide range of therapeutic agents, toxins, and …

Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions

HJ Zhu, DI Appel, YK Peterson, Z Wang, JS Markowitz - Toxicology, 2010 - Elsevier
A series of studies were designed and carried out in order to explore the potential for the
major human hepatic hydrolase, carboxylesterase 1 (hCES1), to serve as a target of …

The impact of carboxylesterases in drug metabolism and pharmacokinetics

L Di - Current drug metabolism, 2019 - ingentaconnect.com
Background: Carboxylesterases (CES) play a critical role in catalyzing hydrolysis of esters,
amides, carbamates and thioesters, as well as bioconverting prodrugs and soft drugs. The …

Carboxylesterase inhibitors: an update

LW Zou, Q Jin, DD Wang, QK Qian… - Current medicinal …, 2018 - ingentaconnect.com
Mammalian carboxylesterases are key serine hydrolases that catalyze the hydrolysis of a
wide variety of ester compounds in the corresponding carboxylic acids and alcohols. In …

Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors

Y Yang, Y Xiong, G Zhu, M Sun, K Zou, Y Zhao… - Chemico-Biological …, 2023 - Elsevier
Abstract Human carboxylesterase 2A (hCES2A) is a key serine hydrolase responsible for
the metabolic clearance of large number of compounds bearing the ester-or amide-bond (s) …